These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 408150)

  • 1. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease.
    Wagener DJ; Haanen C
    Eur J Clin Invest; 1977 Aug; 7(4):289-94. PubMed ID: 408150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
    Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
    Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma activity inducing polymorphonuclear neutrophils (PMN) aggregation, chemotactic plasma activity, and plasma activity augmenting PMN adherence in untreated patients with Hodgkin's disease. Possible relationship to disseminated intravascular complement activation.
    Wierusz-Wysocka B; Wysocki H
    Oncology; 1984; 41(6):409-13. PubMed ID: 6504496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
    Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
    J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between hematic fibrinogen and sedimentation rate of erythrocytes in Hodgkin's disease, reticulosarcoma and lymphosarcoma].
    Girolami A
    Riv Crit Clin Med; 1965 Jun; 65(3):344-9. PubMed ID: 5326288
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors for bone marrow involvement in Hodgkin's disease].
    Kanaev SV; Novikov SN; Zhukova LA; Pozharisskiĭ KM; Leenman EE; Gershanovich ML
    Vopr Onkol; 2001; 47(1):39-44. PubMed ID: 11317533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of bone marrow examination in the staging of Hodgkin's lymphoma: a review of 955 cases seen in a regional cancer centre.
    Howell SJ; Grey M; Chang J; Morgenstern GR; Cowan RA; Deakin DP; Radford JA
    Br J Haematol; 2002 Nov; 119(2):408-11. PubMed ID: 12406078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-aided estimate of tumor burden in Hodgkin's disease: evidence of its primary prognostic importance.
    Gobbi PG; Ghirardelli ML; Solcia M; Di Giulio G; Merli F; Tavecchia L; Bertè R; Davini O; Levis A; Broglia C; Maffè GC; Ilariucci F; Dore R; Ascari E
    J Clin Oncol; 2001 Mar; 19(5):1388-94. PubMed ID: 11230483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
    Brandeis WE; Tan C; Wang Y; Good RA; Day NK
    Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitable immune complexes in Hodgkin's disease.
    Euler HH; Béress R; Moldenhauer I; Löffler H
    Int J Cancer; 1983 Oct; 32(4):437-41. PubMed ID: 6618706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell survival in patients with Hodgkin's disease.
    Lanaro AE; Bosch A; Frĭas Z
    Cancer; 1971 Sep; 28(3):658-61. PubMed ID: 5096930
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum concentrations of cytokines in patients with Hodgkin's disease.
    Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
    Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 20. Hodgkin's disease: a quantitative evaluation by computed tomography of tumor burden.
    Torricelli P; Grimaldi PL; Fiocchi F; Federico M; Romagnoli R
    Clin Imaging; 2004; 28(4):239-44. PubMed ID: 15246472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.